FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/053572 [Registered on: 06/06/2023] Trial Registered Prospectively
Last Modified On: 05/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Curative]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To study the effect of yastimadhu siddha ghrita nasal drop instillation on Dry eye disease.  
Scientific Title of Study   A Randomized Controlled Clinical Study of Yastimadhu Siddha Ghrita Pratimarsha Nasya on Dry Eye Disease.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rebecca Irom 
Designation  MS Scholar Shalakya tantra 
Affiliation  Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital 
Address  Department of Shalakya Tantra,Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital, Satara Road, pune 43
Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital, Satara Road, pune 43
Pune
MAHARASHTRA
411043
India 
Phone  9863132583  
Fax    
Email  beccairom20@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sarita Santosh Mulik 
Designation  Associate Professor 
Affiliation  Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital 
Address  Department of Shalakya Tantra,Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital, Satara Road, pune 43

Pune
MAHARASHTRA
411043
India 
Phone  9175382645  
Fax    
Email  saritamulik9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rebecca Irom 
Designation  MS Scholar Shalakya tantra 
Affiliation  Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital 
Address  Department of Shalakya Tantra,Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital, Satara Road, pune 43

Pune
MAHARASHTRA
411043
India 
Phone  9863132583  
Fax    
Email  beccairom20@gmail.com  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital, Pune-43 
 
Primary Sponsor  
Name  Dr. Rebecca Irom 
Address  Department of Shalakya Tantra, Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rebecca Irom  Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital,Pune.  Department of Shalakya Tantra, Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital, Satara Road, Pune
Pune
MAHARASHTRA 
9863132583

beccairom20@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BV(DU)COA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H048||Other disorders of lacrimal system. Ayurveda Condition: SUSHKAKSHIPAKAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Carboxymethyl cellulose 0.5 % eye dropIt is a lubricating eye drop used to relieve dry eye disease. Dose- 1 drop TDS in both eyes Duration- 15 days
2Intervention ArmDrugClassical(1) Medicine Name: Yashtimadhu siddha ghrita, Reference: Sushruta samhita, uttara tantra 15 / 21-22, Route: Nasal, Dosage Form: Bindu/ Drops (Karna/ Nasa/ Netra), Dose: 2(drops), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 15 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  patients suffering from mild to moderate symptoms of dry eye disease who are willing to participate in the study will be selected 
 
ExclusionCriteria 
Details  Patients showing severe symptoms of dry eye, any ocular surface pathology, any acute nasal pathology, having congenital anomalies of eye, who are one eyed patient and those whose age are below 10 yrs and above 45 yrs will be excluded. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
TFBUT test value to increase by 2-3 secs. Schirmer-I test value to increase by 1-2 units (1mm-2mm)  28 days study with 3 follow up (7th day,14th day & 28th day) 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction of dryness, redness or congestion, itching, burning sensation & eye fatigue.  28 days study with 3 follow up (7th day,14th day & 28th day) 
 
Target Sample Size   Total Sample Size="63"
Sample Size from India="63" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   14/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A randomized controlled clinical study of yastimadhu siddha ghrita pratimarsha nasya will be done on 63 patients presenting with complaints of  Dry eye disease and they will be divided into 3 groups (A, B & C) . Group A will be provided with the trial drug, yastimadhu siddha ghrita and will be advised to instill 2 drops in each nostril every morning for 15 days. Group C will be provided with the control drug, Carboxymethylcellulose 0.5% eyedrop and will be advised to instill one drop three times a day for 15 days. Group B will be provided with both the drugs and will be advised the same. Study will be conducted for 28 days and all observations will be taken & recorded starting from 0th day and follow up will be done on 7th and14th day & on the 28th day observations will be taken for any recurrences. Data recorded will be analized statistically and conclusion will be drawn based on it. 
Close